00896nas a2200181   4500000000100000008004100001100001500042700001300057700001400070700001200084700001400096245011000110856007100220300001000291490000600301520039300307022001400700       2016                            d1 aChowdhry S1 aShukla A1 aD'Souza P1 aDhali T1 aJaiswal P00aTreatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.  uhttp://www.sciencedirect.com/science/article/pii/S2212553116000212  a223-50 v53 a<p>Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.</p>
  a2212-554X